Design of Next Generation Polymyxins with Lower Toxicity: The Discovery of SPR206

Click to copy article linkArticle link copied!

This article is cited by 68 publications.

1. Krishna K. Sharma, Komal Sharma, Kamya Rao, Anku Sharma, Gajanan K. Rathod, Shams Aaghaz, Naina Sehra, Rajesh Parmar, Brett VanVeller, Rahul Jain. Unnatural Amino Acids: Strategies, Designs, and Applications in Medicinal Chemistry and Drug Discovery. Journal of Medicinal Chemistry 2024, 67 (22) , 19932-19965. https://doi.org/10.1021/acs.jmedchem.4c00110
2. Cornelis J. Slingerland, Nathaniel I. Martin. Recent Advances in the Development of Polymyxin Antibiotics: 2010–2023. ACS Infectious Diseases 2024, 10 (4) , 1056-1079. https://doi.org/10.1021/acsinfecdis.3c00630
3. Michael F. T. Koehler, Yi-Chen Chen, Yongsheng Chen, Yuan Chen, James J. Crawford, Matthew R. Durk, Keira Garland, Emily J. Hanan, Robert I. Higuchi, Huiyong Hu, Cuong Q. Ly, Prasuna G. Paraselli, Tucker C. Roberts, Jacob B. Schwarz, Peter A. Smith, Zhiyong Yu, Christopher E. Heise. Lipid Tales: Optimizing Arylomycin Membrane Anchors. ACS Medicinal Chemistry Letters 2023, 14 (11) , 1524-1530. https://doi.org/10.1021/acsmedchemlett.3c00327
4. Cornelis J. Slingerland, Charlotte M. J. Wesseling, Paolo Innocenti, Koen G. C. Westphal, Rosalinde Masereeuw, Nathaniel I. Martin. Synthesis and Evaluation of Polymyxins Bearing Reductively Labile Disulfide-Linked Lipids. Journal of Medicinal Chemistry 2022, 65 (23) , 15878-15892. https://doi.org/10.1021/acs.jmedchem.2c01528
5. Pamela Brown, Omar Abdulle, Steven Boakes, Naomi Divall, Esther Duperchy, Sonia Ganeshwaran, Roy Lester, Stephen Moss, Dean Rivers, Mona Simonovic, Jaspal Singh, Steven Stanway, Antoinette Wilson, Michael J. Dawson. Influence of Lipophilicity on the Antibacterial Activity of Polymyxin Derivatives and on Their Ability to Act as Potentiators of Rifampicin. ACS Infectious Diseases 2021, 7 (4) , 894-905. https://doi.org/10.1021/acsinfecdis.0c00917
6. A-Long Cui, Xin-Xin Hu, Yang Chen, Jie Jin, Hong Yi, Xiu-Kun Wang, Qi-Yang He, Xue-Fu You, Zhuo-Rong Li. Design, Synthesis, and Bioactivity of Cyclic Lipopeptide Antibiotics with Varied Polarity, Hydrophobicity, and Positive Charge Distribution. ACS Infectious Diseases 2020, 6 (7) , 1796-1806. https://doi.org/10.1021/acsinfecdis.0c00056
7. George M. Ongwae, Kelly R. Morrison, Ryan A. Allen, Seonghoon Kim, Wonpil Im, William M. Wuest, Marcos M. Pires. Broadening Activity of Polymyxin by Quaternary Ammonium Grafting. ACS Infectious Diseases 2020, 6 (6) , 1427-1435. https://doi.org/10.1021/acsinfecdis.0c00037
8. Michelle Outeda-García, Andrea Garcia-Pose, Paula Guijarro-Sánchez, Arianna Rodríguez-Coello, Gabriela Alejandra Báez-Barroso, Romina Maceiras, Isaac Alonso-García, Jorge Arca-Suárez, Juan C. Vázquez-Ucha, German Bou, Alejandro Beceiro, , . The novel polymyxin analogue SPR206 exhibits higher activity than colistin against both colistin-susceptible and colistin-resistant strains of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy 2025, https://doi.org/10.1128/aac.01940-24
9. Aye Mya Sithu Shein, Parichart Hongsing, O’Rorke Kevin Smith, Phatthranit Phattharapornjaroen, Kazuhiko Miyanaga, Longzhu Cui, Hitoshi Ishikawa, Mohan Amarasiri, Peter N. Monk, Anthony Kicic, Tanittha Chatsuwan, Daniel Pletzer, Paul G. Higgins, Shuichi Abe, Dhammika Leshan Wannigama. Current and novel therapies for management of Acinetobacter baumannii -associated pneumonia. Critical Reviews in Microbiology 2025, 51 (3) , 441-462. https://doi.org/10.1080/1040841X.2024.2369948
10. Yanan Li, Haoran Mei, Yuanzhen Dong, Jianguang Lu, Xiaoqian Yang, Ying Zhang, Meiqing Feng, Jun Feng. Novel bifunctional antibacterial peptides mediated by a covalent conjugation strategy combat priority multidrug-resistant gram-negative pathogens through dual targets. The Journal of Antibiotics 2025, 78 (6) , 359-369. https://doi.org/10.1038/s41429-025-00822-x
11. Dominik Heimann, Daniel Kohnhäuser, Alexandra Jana Kohnhäuser, Mark Brönstrup. Antibacterials with Novel Chemical Scaffolds in Clinical Development. Drugs 2025, 85 (3) , 293-323. https://doi.org/10.1007/s40265-024-02137-x
12. Kamlesh Vishwakarma, Anmol Bisht, Parveen Kumar, Satish Kumar, Jawed Akhter, Anurag Payasi, Saransh Chaudhary, Anmol Aggarwal. Toxicokinetic profiling of VRP-034: Evaluating its potential in mitigating polymyxin-B-associated nephrotoxicity. International Journal of Antimicrobial Agents 2025, 65 (2) , 107393. https://doi.org/10.1016/j.ijantimicag.2024.107393
13. Xiaobao Chen, Li Liu, Weidan Wang, Yuan Yuan, Wei Wang. Nanoformulation of Polymyxin E Through Complex Coacervation: A Pharmacokinetic Analysis. Pharmaceutics 2025, 17 (1) , 76. https://doi.org/10.3390/pharmaceutics17010076
14. Yizhen Huang, Mingrui Liao, Xuzhi Hu, Honghua Hu, Haoning Gong. Advances in the clinical treatment of multidrug-resistant pathogens using polymyxins. Journal of Antimicrobial Chemotherapy 2024, 79 (12) , 3210-3229. https://doi.org/10.1093/jac/dkae344
15. A-Long Cui, He-Xian Yang, Hong Yi, Miao Lv, Xiao-Jiong Peng, Guang-Hui Zheng, Zhuo-Rong Li. Design, synthesis, and bioactivity investigation of novel cyclic lipopeptide antibiotics targeting top-priority multidrug-resistant gram-negative bacteria. European Journal of Medicinal Chemistry 2024, 280 , 116924. https://doi.org/10.1016/j.ejmech.2024.116924
16. Shio-Shin Jean, Chia-Ying Liu, Tzu-Yu Huang, Chih-Cheng Lai, I-Min Liu, Po-Chuen Hsieh, Po-Ren Hsueh. Potentially effective antimicrobial treatment for pneumonia caused by isolates of carbapenem-resistant and extensively drug-resistant Acinetobacter baumannii complex species: what can we expect in the future?. Expert Review of Anti-infective Therapy 2024, 22 (12) , 1171-1187. https://doi.org/10.1080/14787210.2024.2412637
17. Guang-Yu Liu, Dan Yu, Mei-Mei Fan, Xu Zhang, Ze-Yu Jin, Christoph Tang, Xiao-Fen Liu. Antimicrobial resistance crisis: could artificial intelligence be the solution?. Military Medical Research 2024, 11 (1) https://doi.org/10.1186/s40779-024-00510-1
18. Jiraborrirak Charoenpattarapreeda, Werner Tegge, Chunfa Xu, Kirsten Harmrolfs, Bettina Hinkelmann, Hannah Wullenkord, Sven‐Kevin Hotop, Ulrike Beutling, Katharina Rox, Mark Brönstrup. Die Click‐to‐Release‐Aktivierung des Reserveantibiotikums Colistin am Zielort verringert dessen Nierentoxizität. Angewandte Chemie 2024, 136 (47) https://doi.org/10.1002/ange.202408360
19. Jiraborrirak Charoenpattarapreeda, Werner Tegge, Chunfa Xu, Kirsten Harmrolfs, Bettina Hinkelmann, Hannah Wullenkord, Sven‐Kevin Hotop, Ulrike Beutling, Katharina Rox, Mark Brönstrup. A Targeted Click‐to‐Release Activation of the Last‐Resort Antibiotic Colistin Reduces its Renal Cell Toxicity. Angewandte Chemie International Edition 2024, 63 (47) https://doi.org/10.1002/anie.202408360
20. Anurag Payasi, Manoj Kumar Yadav, Saransh Chaudhary, Anmol Aggarwal, . Evaluating nephrotoxicity reduction in a novel polymyxin B formulation: insights from a 3D kidney-on-a-chip model. Antimicrobial Agents and Chemotherapy 2024, 68 (10) https://doi.org/10.1128/aac.00219-24
21. Tae‐Ung Na, Veronika Sander, Alan J. Davidson, Rolland Lin, Yann O. Hermant, Madeleine T. Hardie Boys, Daniel Pletzer, Georgia Campbell, Scott A. Ferguson, Gregory M. Cook, Jane R. Allison, Margaret A. Brimble, Brian H. Northrop, Alan J. Cameron. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β ‐Keto Amides. Angewandte Chemie 2024, 136 (39) https://doi.org/10.1002/ange.202407764
22. Tae‐Ung Na, Veronika Sander, Alan J. Davidson, Rolland Lin, Yann O. Hermant, Madeleine T. Hardie Boys, Daniel Pletzer, Georgia Campbell, Scott A. Ferguson, Gregory M. Cook, Jane R. Allison, Margaret A. Brimble, Brian H. Northrop, Alan J. Cameron. Allenamides as a Powerful Tool to Incorporate Diversity: Thia‐Michael Lipidation of Semisynthetic Peptides and Access to β ‐Keto Amides. Angewandte Chemie International Edition 2024, 63 (39) https://doi.org/10.1002/anie.202407764
23. Ping Zeng, Honglan Wang, Pengfei Zhang, Sharon Shui Yee Leung. Unearthing naturally-occurring cyclic antibacterial peptides and their structural optimization strategies. Biotechnology Advances 2024, 73 , 108371. https://doi.org/10.1016/j.biotechadv.2024.108371
24. Craig R. MacNair, Steven T. Rutherford, Man-Wah Tan. Alternative therapeutic strategies to treat antibiotic-resistant pathogens. Nature Reviews Microbiology 2024, 22 (5) , 262-275. https://doi.org/10.1038/s41579-023-00993-0
25. Size Li, Xu Zhu, Guoying Cao, Jufang Shen, Xu Zhu, Jicheng Yu, Xiaojie Wu, Jufang Wu, Haijing Yang, Nanyang Li, Yingying Hu, Jingjing Wang, Haihui Huang, Jing Zhang, . Pharmacokinetics and safety of EVER206, a novel polymyxin antimicrobial, in healthy Chinese subjects. Antimicrobial Agents and Chemotherapy 2024, https://doi.org/10.1128/aac.01563-23
26. Mathieu Varache, Siân Rizzo, Edward J. Sayers, Lucy Newbury, Anna Mason, Chia-Te Liao, Emilie Chiron, Nathan Bourdiec, Adam Jones, Donald J. Fraser, Philip R. Taylor, Arwyn T. Jones, David W. Thomas, Elaine L. Ferguson. Dextrin conjugation to colistin inhibits its toxicity, cellular uptake and acute kidney injury in vivo. RSC Pharmaceutics 2024, 1 (1) , 68-79. https://doi.org/10.1039/D3PM00014A
27. David L. Paterson. Antibacterial agents active against Gram Negative Bacilli in phase I, II, or III clinical trials. Expert Opinion on Investigational Drugs 2024, 33 (4) , 371-387. https://doi.org/10.1080/13543784.2024.2326028
28. Cédric Couturier, Quentin Ronzon, Giulia Lattanzi, Iain Lingard, Sebastien Coyne, Veronique Cazals, Nelly Dubarry, Stephane Yvon, Corinne Leroi-Geissler, Obdulia Rabal Gracia, Joanne Teague, Sylvie Sordello, David Corbett, Caroline Bauch, Chantal Monlong, Lloyd Payne, Thomas Taillier, Hazel Fuchs, Mark Broenstrup, Peter H. Harrison, Lucile Moynié, Abirami Lakshminarayanan, Tiberiu-Marius Gianga, Rohanah Hussain, James H. Naismith, Michael Mourez, Eric Bacqué, Fredrik Björkling, Jean-Francois Sabuco, Henrik Franzyk. Studies of antibacterial activity (in vitro and in vivo) and mode of action for des-acyl tridecaptins (DATs). European Journal of Medicinal Chemistry 2024, 265 , 116097. https://doi.org/10.1016/j.ejmech.2023.116097
29. Jacinda C. Abdul-Mutakabbir, Nana Sakyi Opoku, Karen K. Tan, Peter Jorth, Victor Nizet, Hansel M. Fletcher, Keith S. Kaye, Michael J. Rybak. Determining Susceptibility and Potential Mediators of Resistance for the Novel Polymyxin Derivative, SPR206, in Acinetobacter baumannii. Antibiotics 2024, 13 (1) , 47. https://doi.org/10.3390/antibiotics13010047
30. Rajib Dey, Sudip Mukherjee, Riya Mukherjee, Jayanta Haldar. Small molecular adjuvants repurpose antibiotics towards Gram-negative bacterial infections and multispecies bacterial biofilms. Chemical Science 2023, 15 (1) , 259-270. https://doi.org/10.1039/D3SC05124B
31. Cornelis J. Slingerland, Vladyslav Lysenko, Samhita Chaudhuri, Charlotte M. J. Wesseling, Devon Barnes, Rosalinde Masereeuw, Nathaniel I. Martin. Semisynthetic polymyxins with potent antibacterial activity and reduced kidney cell toxicity. RSC Medicinal Chemistry 2023, 14 (11) , 2417-2425. https://doi.org/10.1039/D3MD00456B
32. Jon B. Bruss, Justin Bader, Kamal A. Hamed, . Safety and pharmacokinetics of SPR206 in subjects with varying degrees of renal impairment. Antimicrobial Agents and Chemotherapy 2023, 67 (11) https://doi.org/10.1128/aac.00505-23
33. Marta K. Ruest, Brittany S. I. Supina, Jonathan J. Dennis, . Bacteriophage steering of Burkholderia cenocepacia toward reduced virulence and increased antibiotic sensitivity. Journal of Bacteriology 2023, 205 (10) https://doi.org/10.1128/jb.00196-23
34. Akshay Sabnis, Andrew M. Edwards. Lipopolysaccharide as an antibiotic target. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research 2023, 1870 (7) , 119507. https://doi.org/10.1016/j.bbamcr.2023.119507
35. Keith A. Rodvold, Justin Bader, Jon B. Bruss, Kamal Hamed. Pharmacokinetics of SPR206 in Plasma, Pulmonary Epithelial Lining Fluid, and Alveolar Macrophages following Intravenous Administration to Healthy Adult Subjects. Antimicrobial Agents and Chemotherapy 2023, 67 (7) https://doi.org/10.1128/aac.00426-23
36. Lindsey A. Carfrae, Kenneth Rachwalski, Shawn French, Rodion Gordzevich, Laura Seidel, Caressa N. Tsai, Megan M. Tu, Craig R. MacNair, Olga G. Ovchinnikova, Bradley R. Clarke, Chris Whitfield, Eric D. Brown. Inhibiting fatty acid synthesis overcomes colistin resistance. Nature Microbiology 2023, 8 (6) , 1026-1038. https://doi.org/10.1038/s41564-023-01369-z
37. Christian M. Gill, David P. Nicolau. In Vivo Pharmacodynamic Profile of EVER206, a Novel Polymyxin Antimicrobial, against Gram-Negative Bacteria in the Murine Thigh Infection Model. Antimicrobial Agents and Chemotherapy 2023, 67 (5) https://doi.org/10.1128/aac.01738-22
38. Yanan Li, Yuanzhen Dong, Jianguang Lu, Jinhua Zhang, Meiqing Feng, Jun Feng. Design, synthesis and antibacterial activity of novel colistin derivatives with thioether bond-mediated cyclic scaffold. The Journal of Antibiotics 2023, 76 (5) , 260-269. https://doi.org/10.1038/s41429-023-00606-1
39. Roser Segovia, Mireia Díaz-Lobo, Yolanda Cajal, Marta Vilaseca, Francesc Rabanal. Linker-Free Synthesis of Antimicrobial Peptides Using a Novel Cleavage Reagent: Characterisation of the Molecular and Ionic Composition by nanoESI-HR MS. Pharmaceutics 2023, 15 (4) , 1310. https://doi.org/10.3390/pharmaceutics15041310
40. Sebastian Walesch, Joy Birkelbach, Gwenaëlle Jézéquel, F P Jake Haeckl, Julian D Hegemann, Thomas Hesterkamp, Anna K H Hirsch, Peter Hammann, Rolf Müller. Fighting antibiotic resistance—strategies and (pre)clinical developments to find new antibacterials. EMBO reports 2023, 24 (1) https://doi.org/10.15252/embr.202256033
41. Yuanyuan Qian, Shahriar Mobashery, Jed F. Fisher. Macrolide, lincosamide, glycopeptide, and other antibacterial antibiotics. 2023, 157-213. https://doi.org/10.1016/B978-0-323-90575-6.00008-9
42. Freddy A Bernal, Peter Hammann, Florian Kloss. Natural products in antibiotic development: is the success story over?. Current Opinion in Biotechnology 2022, 78 , 102783. https://doi.org/10.1016/j.copbio.2022.102783
43. Kade D. Roberts, Yan Zhu, Mohammad A. K. Azad, Mei-Ling Han, Jiping Wang, Lynn Wang, Heidi H. Yu, Andrew S. Horne, Jo-Anne Pinson, David Rudd, Nicolas H. Voelcker, Nitin A. Patil, Jinxin Zhao, Xukai Jiang, Jing Lu, Ke Chen, Olga Lomovskaya, Scott J. Hecker, Philip E. Thompson, Roger L. Nation, Michael N. Dudley, David C. Griffith, Tony Velkov, Jian Li. A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens. Nature Communications 2022, 13 (1) https://doi.org/10.1038/s41467-022-29234-3
44. Abdullah Tarık Aslan, Murat Akova, David L. Paterson. Next-Generation Polymyxin Class of Antibiotics: A Ray of Hope Illuminating a Dark Road. Antibiotics 2022, 11 (12) , 1711. https://doi.org/10.3390/antibiotics11121711
45. Selena Chiu, Anna M. Hancock, Bob W. Schofner, Katherine J. Sniezek, Nashaly Soto-Echevarria, Gabrielle Leon, Darshan M. Sivaloganathan, Xuanqing Wan, Mark P. Brynildsen. Causes of polymyxin treatment failure and new derivatives to fill the gap. The Journal of Antibiotics 2022, 75 (11) , 593-609. https://doi.org/10.1038/s41429-022-00561-3
46. Sébastien Reig, Audrey Le Gouellec, Sophie Bleves. What Is New in the Anti–Pseudomonas aeruginosa Clinical Development Pipeline Since the 2017 WHO Alert?. Frontiers in Cellular and Infection Microbiology 2022, 12 https://doi.org/10.3389/fcimb.2022.909731
47. Flora Cruz-López, Adrian Martínez-Meléndez, Rayo Morfin-Otero, Eduardo Rodriguez-Noriega, Héctor J. Maldonado-Garza, Elvira Garza-González. Efficacy and In Vitro Activity of Novel Antibiotics for Infections With Carbapenem-Resistant Gram-Negative Pathogens. Frontiers in Cellular and Infection Microbiology 2022, 12 https://doi.org/10.3389/fcimb.2022.884365
48. Kristina Klobucar, Eric D. Brown. New potentiators of ineffective antibiotics: Targeting the Gram-negative outer membrane to overcome intrinsic resistance. Current Opinion in Chemical Biology 2022, 66 , 102099. https://doi.org/10.1016/j.cbpa.2021.102099
49. Seetharama D. Jois. Basic Concepts of Design of Peptide-Based Therapeutics. 2022, 1-50. https://doi.org/10.1007/978-3-031-04544-8_1
50. Kesia Esther da Silva, Luana Rossato, Andressa Ferraz Leite, Simone Simionatto. Overview of polymyxin resistance in Enterobacteriaceae. Revista da Sociedade Brasileira de Medicina Tropical 2022, 55 https://doi.org/10.1590/0037-8682-0349-2021
51. Jon Bruss, Troy Lister, Vipul K. Gupta, Emily Stone, Lisa Morelli, Yang Lei, David Melnick. Single- and Multiple-Ascending-Dose Study of the Safety, Tolerability, and Pharmacokinetics of the Polymyxin Derivative SPR206. Antimicrobial Agents and Chemotherapy 2021, 65 (10) https://doi.org/10.1128/AAC.00739-21
52. Bee Ha Gan, Josephine Gaynord, Sam M. Rowe, Tomas Deingruber, David R. Spring. The multifaceted nature of antimicrobial peptides: current synthetic chemistry approaches and future directions. Chemical Society Reviews 2021, 50 (13) , 7820-7880. https://doi.org/10.1039/D0CS00729C
53. Mike Dawson, Troy Lister. Polymyxins as Antibacterials and Antibiotic Potentiators. 2021, 1-19. https://doi.org/10.1002/0471266949.bmc290
54. Wenyi Li, Frances Separovic, Neil M. O'Brien-Simpson, John D. Wade. Chemically modified and conjugated antimicrobial peptides against superbugs. Chemical Society Reviews 2021, 50 (8) , 4932-4973. https://doi.org/10.1039/D0CS01026J
55. Randi L. Guest, Steven T. Rutherford, Thomas J. Silhavy. Border Control: Regulating LPS Biogenesis. Trends in Microbiology 2021, 29 (4) , 334-345. https://doi.org/10.1016/j.tim.2020.09.008
56. Sue C. Nang, Mohammad A.K. Azad, Tony Velkov, Qi (Tony) Zhou, Jian Li. Rescuing the Last-Line Polymyxins: Achievements and Challenges. Pharmacological Reviews 2021, 73 (2) , 679-728. https://doi.org/10.1124/pharmrev.120.000020
57. Qidi Kong, Yushe Yang. Recent advances in antibacterial agents. Bioorganic & Medicinal Chemistry Letters 2021, 35 , 127799. https://doi.org/10.1016/j.bmcl.2021.127799
58. Gregory Upert, Anatol Luther, Daniel Obrecht, Philipp Ermert. Emerging peptide antibiotics with therapeutic potential. Medicine in Drug Discovery 2021, 9 , 100078. https://doi.org/10.1016/j.medidd.2020.100078
59. Matteo Bassetti, Laura Labate, Chiara Russo, Antonio Vena, Daniele Roberto Giacobbe. Therapeutic options for difficult-to-treat A cinetobacter baumannii infections: a 2020 perspective. Expert Opinion on Pharmacotherapy 2021, 22 (2) , 167-177. https://doi.org/10.1080/14656566.2020.1817386
60. Joana Stokniene, Lydia C. Powell, Olav A. Aarstad, Finn L. Aachmann, Philip D. Rye, Katja E. Hill, David W. Thomas, Elaine L. Ferguson. Bi-Functional Alginate Oligosaccharide–Polymyxin Conjugates for Improved Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections. Pharmaceutics 2020, 12 (11) , 1080. https://doi.org/10.3390/pharmaceutics12111080
61. Liam J Stephens, Melissa V Werrett, Adam C Sedgwick, Steven D Bull, Philip C Andrews. Antimicrobial Innovation: a Current Update and Perspective on the Antibiotic Drug Development Pipeline. Future Medicinal Chemistry 2020, 12 (22) , 2035-2065. https://doi.org/10.4155/fmc-2020-0225
62. Yawei Zhang, Chunjiang Zhao, Qi Wang, Xiaojuan Wang, Hongbin Chen, Henan Li, Feifei Zhang, Hui Wang. Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli. Journal of Antimicrobial Chemotherapy 2020, 75 (9) , 2609-2615. https://doi.org/10.1093/jac/dkaa217
63. Manigandan Krishnan, Joonhyeok Choi, Ahjin Jang, Yangmee Kim. A Novel Peptide Antibiotic, Pro10-1D, Designed from Insect Defensin Shows Antibacterial and Anti-Inflammatory Activities in Sepsis Models. International Journal of Molecular Sciences 2020, 21 (17) , 6216. https://doi.org/10.3390/ijms21176216
64. Carole Ayoub Moubareck. Polymyxins and Bacterial Membranes: A Review of Antibacterial Activity and Mechanisms of Resistance. Membranes 2020, 10 (8) , 181. https://doi.org/10.3390/membranes10080181
65. Pamela Brown, Omar Abdulle, Steven Boakes, Esther Duperchy, Stephen Moss, Mona Simonovic, Steven Stanway, Antoinette Wilson, Michael J. Dawson. Direct modifications of the cyclic peptide Polymyxin B leading to analogues with enhanced in vitro antibacterial activity. Bioorganic & Medicinal Chemistry Letters 2020, 30 (11) , 127163. https://doi.org/10.1016/j.bmcl.2020.127163
66. Thea Brennan-Krohn, Roman Manetsch, George A. O'Doherty, James E. Kirby. New strategies and structural considerations in development of therapeutics for carbapenem-resistant Enterobacteriaceae. Translational Research 2020, 220 , 14-32. https://doi.org/10.1016/j.trsl.2020.02.008
67. Ursula Theuretzbacher, Karen Bush, Stephan Harbarth, Mical Paul, John H. Rex, Evelina Tacconelli, Guy E. Thwaites. Critical analysis of antibacterial agents in clinical development. Nature Reviews Microbiology 2020, 18 (5) , 286-298. https://doi.org/10.1038/s41579-020-0340-0
68. Yasunari Otsuka. Potent Antibiotics Active against Multidrug-Resistant Gram-Negative Bacteria. Chemical and Pharmaceutical Bulletin 2020, 68 (3) , 182-190. https://doi.org/10.1248/cpb.c19-00842